Highlights of the first day of the 2023 ESC Congress: 1- SGLT2 inhibitors are recommended as class I in HF mrEF and HFpEF (dapagliflozin and empagliflozin) 2- there is no change in the strategies of antithrombotic treatment in patients with ACS : Aspirin + P2Y12 inhibtirs for 12 months flooded by aspirin alone for life long (class I). 3- Surgery is recommended for early Prosthetic valve endocarditis (less than 6 months) with new valve replacement and complete debridement (class IC) 4- ACS management in cancer patients: Invasive strategy if the life expectancy >6 months Conservative management if poor prognosis Antithrombotic therapy according to platelet count 5- SGLT2 inhibitors are recommended as first line treatment ( class I) in type 2 diabetic patients with established ASCVD (to reduce CV risk independent of glucose control , in type2 diabetic patients with HF(to reduce HF hospitalizations ), and in type 2 diabetic patients with CKD (to reduce ...
Cardiology Notes: Clinical Cases including ECG, Echocardiography, Cath, and MOCK Exams to sharpen your cardiology data interpretation skills. Healthcare is stressful!!! Learning cardiology shouldn't be !!!